Pharma October 30, 2026 0 Comments

EXCLUSIVE: India orders Sun Pharma to halt eye-care drug production at plant after quality lapses – Reuters

EXCLUSIVE: India orders Sun Pharma to halt eye-care drug production at plant after quality lapses Reuters

Read the full story at source →

Add your Biographical Information. Edit your Profile now.

How does the expansion of high-containment biosafety infrastructure enhance India’s preparedness against biological disasters? Explain why integrating One Health surveillance is essential for preventing zoonotic disease outbreaks. – GKToday – GK Today

Next post

CAF makes u-turn on AFCON format, tournament to be held every two years

0

Pharma exports rise 3% to over $8 bn in Q2 on higher EU trade – pharma.economictimes.indiatimes.com

0

Pharma M&A deal value, volumes declines in Sep quarter, PE buyouts rebound – pharma.economictimes.indiatimes.com

0

India’s Pharma Exports Grow 4.9% To $16.14 Bn In April-September 2026 – BW Businessworld

Post Comment Cancel reply